Key result
Furosemide exposure explains ~0.4% of daily renal function variation in hospitalized HF patients.
Why the study?
Does furosemide dosing affect acute changes in renal function during hospitalization for heart failure?
Cohort
Does furosemide dosing affect acute changes in renal function during hospitalization for heart failure?
Furosemide dosing explains very little of the variability in worsening renal function during heart failure hospitalizations, suggesting other unidentified factors are more important drivers.
Furosemide explains minimal renal function variability in HF hospitalization; leaves open dominant drivers and should not yet change diuretic practice.
BACKGROUND: Worsening renal function (WRF) during heart failure (HF) hospitalization is an accepted correlate of poor prognosis. Loop diuretics are increasingly being considered as a potential cause of worsened HF outcomes, perhaps via WRF. However, the magnitude of worsening in renal function attributable to loop diuretics has not been quantified. METHODS: This was a retrospective cohort study of patients who received care from a large health system and had a primary hospital discharge diagnosis of HF between Jan 1, 2000 and June 30, 2008. Patients with preexisting end-stage renal disease were excluded. Daily creatinine (Cr) measurements, furosemide dosing (only loop diuretic on hospital formulary), and radiocontrast dye studies were collected using administrative data. Day-to-day changes in Cr and MDRD estimated glomerular filtration (eGFR) were calculated. The first Cr or eGFR value during hospitalization or in the emergency department was considered baseline. Generalized estimating equations were used to test the association furosemide exposure over previous 2 days to the daily change in Cr and eGFR. Covariates included undergoing radiocontrast study, age, race, gender, and baseline Cr or eGFR. Furosemide exposure accounted for only 0.4% and 0.1% of the variation in Cr and eGFR changes, respectively. Undergoing radiocontrast study, African American race, and higher age were associated with day-to-day creatinine increases (all p<0.01). Reanaysis after classifying furosemide exposure into low (<40mg/day), medium (40-100mg/day), and high (>100mg/day) and censoring patients-days after radiocontrast exposure did not significantly affect the magnitude of the worsening renal function. CONCLUSIONS: While loop diuretic exposure is statistically associated with WRF among hospitalized HF patients, the associated magnitude of renal function change is very small, and loop diuretics explain little of the variability in renal function during hospitalization. More important explanatory factors likely exist but remain unidentified.
No takes yet. Share an insight, caveat, or question.
El-Refai et al. (2011) conducted a cohort in Heart failure. Furosemide exposure was evaluated on Daily change in creatinine and eGFR (0.4% and 0.1% of variation explained). Furosemide exposure accounted for only 0.4% and 0.1% of the variation in daily creatinine and eGFR changes, respectively, among hospitalized heart failure patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: